Opportunity Alert: New Funding Opportunity at NCI Focuses on Health Information

Apply Today!   New NCI SBIR Program   Announcement:
Innovative Health Information Technology for
Broad Adoption by Healthcare Systems and Consumers

Upcoming Receipt Date:   August 5, 2012

The National Cancer   Institute (NCI) Small Business Innovation Research (SBIR) Program has   announced a new funding opportunity, aimed at accelerating   the development and commercialization of consumer health information technology   products that translate the behavioral and communication science evidence   base for the prevention and control of cancer and other chronic diseases.   With up to $1.5M per Phase I/II grant, this new Program Announcement encourages small   businesses to apply for funding that will further develop products to benefit  consumers, patients, caregivers, and health care providers.

The NCI and their co-funding  partner, the National Library of Medicine, are interested in supporting  the growth and dissemination of evidence-based health information  technology products that validate user-centric research outcomes and have  the potential to:

  • Prevent or reduce the risk of cancer
  • Facilitate patient-provider communication and/or
  • Improve disease outcomes in consumer and clinical settings

To view the full Program Announcement, please visit:
PA-12-196, Innovative Health Information Technology for Broad Adoption by Healthcare Systems and Consumers (SBIR) (R44)
Receipt Dates: August 5, 2012; December 5, 2012

A non-exclusive list of product examples relevant to this funding opportunity are available at: http://sbir.cancer.gov/resource/hit/.

Additional Details:

  • Applicants who have already received Phase I SBIR  funding applicable to this Program Announcement may submit a Phase II;  others may submit a Fast-Track application.
  • Please note, applicants are strongly advised to  establish a partnership with large businesses (e.g. commercial IT firms, EMR vendors, healthcare systems/payers, pharma, healthcare  organizations, etc.) before the application is submitted.
  • This FOA is expected to promote partnerships between   SBC’s and large businesses or health-related organizations with the  capacity to fully commercialize and disseminate the product. Consistent  with the goals of the SBIR funding initiatives, Phase II and Fast-Track  SBIR applicants must submit a Commercialization Plan, which should   include details on the commercialization and dissemination of the  proposed product.
  • Partners in this PA will be asked to sign a legal  document, before the grant commences, that addresses intellectual  property and profit sharing. To view a sample SBIR partnership IP agreement, please click here.
  • Applicants who adhere to these requests will receive  competitive preference and funding priority.

For more information about this program announcement and details on how to apply, please click here.

For a complete list of funding opportunities from the NCI SBIR & STTR   Programs, please visit: http://sbir.cancer.gov/funding/receipt_dates.asp.

The SBIR & STTR   Programs are NCI’s engine of innovation for developing and commercializing   novel technologies and products to prevent, diagnose, and treat cancer. The   SBIR & STTR Programs are government set-aside programs for domestic small   businesses to engage in research and development that has the potential for   commercialization and public benefit.


Posted in AZBio News, Opportunities, Uncategorized.